Skip to main content
Javid Fazili, MD, Gastroenterology, Oklahoma City, OK, OU Health


Gastroenterology Oklahoma City, OK

Hepatology & Liver Transplantation

Professor of Medicine( Gastroenterology and Hepatology) University of Oklahoma health sciences

Dr. Fazili is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Fazili's full profile

Already have an account?

Education & Training

  • Sidney Kimmel Medical College at Thomas Jefferson University
    Sidney Kimmel Medical College at Thomas Jefferson UniversityFellowship, Transplant Hepatology, 2000 - 2001
  • Albert Einstein Healthcare Network
    Albert Einstein Healthcare NetworkFellowship, Gastroenterology, 1997 - 2000
  • Nassau University Medical Center
    Nassau University Medical CenterResidency, Internal Medicine, 1994 - 1997
  • Government Medical College of Jammu and Kashmire
    Government Medical College of Jammu and KashmireClass of 1987

Certifications & Licensure

  • OK State Medical License
    OK State Medical License 2001 - 2022
  • PA State Medical License
    PA State Medical License 1998 - 2002
  • American Board of Internal Medicine Gastroenterology
  • American Board of Internal Medicine Transplant Hepatology

Awards, Honors, & Recognition

  • Oklahoma's Top Doctors 2012-2020
  • Fellow AASLD (FAASLD) American Association for the Study of LIver Disease
  • Fellow ACP (FACP) 2015
  • Join now to see all

Publications & Presentations


Journal Articles

  • Mystery of Hepatitis E Virus: Recent Advances in Its Diagnosis and Management  
    Aftab Ahmed, Ijlal Akbar Ali, Hira Ghazal, Javid Fazili, Salman Nusrat, Intl J of Hepatology, 1/1/2015
  • A randomized controlled trial adding fluvastatin to peginterferon and ribavirin for naïve genotype 1 hepatitis C patients  
    T. Bader, L.D. Hughes, J. Fazili, B. Frost, M. Dunnam, A. Gonterman, M. Madhoun and C.E. Aston, Journal of Viral Hepatitis, 1/1/2013
  • Outcome of a Hepatitis C Outbreak among Patients in a Pain Management Clinic  
    Fazili J, Mallonee S, Tierney WM, Bader TF, Sachdev AK, Bird PC, Schmidt RD, Mesiya SA, Lackey CL, Digestive Diseases and Sciences, 1/1/2010
  • Join now to see all

Books/Book Chapters


  • Expecting the Unexpected: Black Cohosh-induced Hepatotoxicity Leading to Early Cirrhosis.
    Khadija Chaudrey, Muhammad S. Khan, Javid Fazili, ACG, 1/1/2013
  • Early Results of a Phase II RCT Trial of Adding Fluvastatin to Peginterferon Alfa 2a and Ribavirin.
    Ted Bader, Diane Hughes, Javid Fazili, Monica Dunnam, Joe Cardello, and Michael Bronze, DDW, 1/1/2010
  • The impact of Filgrastim and Epotein use on sustained viral response (SVR) rates in Hepatitis C patients treated with Peg-Interferon and Ribavirin.
    Waqar Ahmad, Diane Hughes, Monica Dunnam, Qaiser Khan and, Javid Fazili, ACG, 1/1/2008
  • Join now to see all


  • Hepatitis C Management Update. 
    Oklahoma Health Sciences Center - 1/15/2014
  • Hepatitis E: New Insights to Epidemiology and Clinical Manifestations. 
    Oklahoma Health Sciences Center, Department of Medicine - 1/5/2014
  • Hepatitis C, Interferon Free Treatment Options (The Beginning of a New Era?). 
    Oklahoma Health Sciences Center - 1/20/2013
  • Join now to see all


  • Endoscopic injection sclerotherapy for bleeding esophageal varices in patients with extra hepatic portal hypertension. 
    Javid Fazili, M.D.

Press Mentions

  • Spontaneous Intramural Esophageal Hematoma
    Spontaneous Intramural Esophageal HematomaApril 22nd, 2017


  • fellow, AASLD
  • member, AASLD
  • Fellow, ACP
  • Membership/mentorship committee, AASLD

Professional Memberships

Hospital Affiliations